DAFNA Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

DAFNA Capital Management’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-171,083	Closed	-$790K	–	88
2020 Q3	$790K	Sell	171,083 -834,308	-83%	-$2.75M	0.26%	60
2020 Q2	$2.83M	Sell	1,005,391 -16,175	-2%	-$51.9K	0.82%	34
2020 Q1	$2.49M	Buy	+1,021,566	New	+$3.69M	1.04%	28

Other funds holding SIOX

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sassicaia Capital Advisers Jericho, New York $88.8M AUM 146.47% 1-Year Est. Return

Verition Fund Management

Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return